← Evidence map

ArticleOncoTargets and therapy2022

Efficacy of Disitamab Vedotin in Treating HER2 2+/FISH- Gastric Cancer.

Li Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35321517